Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA®... (to avoid long-term injury. Call your...)

HOME >> MEDICINE >> TECHNOLOGY

Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA®

Date:11/19/2010

to avoid long-term injury.

Call your doctor right away if you start thinking about suicide or wanting to hurt yourself.

INVEGA® SUSTENNA® can make some people feel dizzy, sleepy, or less alert. Until you know how you are going to respond to INVEGA® SUSTENNA®, be careful driving a car, operating machines, or doing things that require you to be alert.

This medicine may make you more sensitive to heat. You may have trouble cooling off or be more likely to become dehydrated. Be careful when you exercise or spend time doing things that make you warm.

Some medications interact with INVEGA® SUSTENNA®. Please inform your healthcare professional of any medications or supplements that you are taking.

INVEGA® SUSTENNA® should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures.

Inform your healthcare professional if you become pregnant or intend to become pregnant during therapy with INVEGA® SUSTENNA®.

Do not drink alcohol while you are taking INVEGA® SUSTENNA®.

In a study of people taking INVEGA® SUSTENNA®, common side effects in the treatment of schizophrenia were reactions at the injection site, sleepiness, dizziness, feeling of inner restlessness, and abnormal muscle movements, including tremor (shaking), shuffling, uncontrolled involuntary movements, and abnormal movements of the eyes.

This is not a complete list of all possible side effects. Ask your doctor or treatment team if you have any questions or want more information.

If you have any questions about INVEGA® SUSTENNA® or your therapy, talk with your doctor.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.Media Contact:Greg Panico, John
'/>"/>

SOURCE Ortho-McNeil Janssen Scientific Affairs, L.L.C.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin

Post Your Comments:

(Date:5/21/2013)... May 21, 2013 BioRestorative Therapies, Inc. ("BRT" or ... focused on developing stem cell based therapies for various ... , its President and CEO, will be presenting at ... will be held on Thursday, May 30, 2013 at ... Street in New York City. Mr. Weinreb,s presentation will ...

(Date:5/21/2013)... May 21, 2013 AcelRx Pharmaceuticals, Inc. ... pharmaceutical company focused on the development and ... of acute and breakthrough pain, today announced ... Phase 3 study of its investigational sublingual ... System), the primary efficacy endpoint was achieved. ...

(Date:5/21/2013)... RxAlly , a first-of-its-kind alliance of ... publication of a white paper entitled Personalized Pharmacist ... white paper highlights an unprecedented solution for improving ... to avert strains on the health care system. ... range of individually-tailored, pharmacist-provided clinical and consultative services ...

[0] BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference [0] Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain [0] RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care

... 2011 Verilogue, the physician-patient dialogue expert, today ... initiatives, including CareCoach.com, the company,s unique service that ... caregivers and their physicians. The company will be ... e-Patient Connections; the Hyatt at Bellevue; ...

... YORK, Sept. 20, 2011 Reportlinker.com announces ... available in its catalogue: ... Outlook to 2017 ... Africa Cardiovascular Devices Market Outlook to 2017 ...

Verilogue to Present at Upcoming Health IT and Patient-Focused Conferences Middle East and Africa Cardiovascular Devices Market Outlook to 2017

(Date:5/21/2013)... Benefit Express Services, LLC, a leader in ... will be hosting a free Workplace Wellness webinar on ... The presentation will focus on making sure your workplace ... Health Care Reform Requirements. The team will also share ... Express regularly hosts free educational webinars on issues that ...

(Date:5/21/2013)... Three major Ohio universities and four hospitals have ... a new collaborative research program aimed exclusively at finding ... Dimes intends to invest $10 million in the program ... Prematurity Research Center -- Ohio Collaborative is a unique ... the March of Dimes. "This new transdisciplinary, team-based research ...

(Date:5/21/2013)... 2013 EMBO announced today that 52 outstanding researchers ... membership. Forty-three of the researchers reside in Europe and ... nine Associate Members from Canada, China, India, Japan and ... 1600 life scientists. , "Our members are the basis ... Maria Leptin said. "We have been building our network ...

(Date:5/21/2013)... Healthcare Solutions, the parent company ... announced that it was honored to receive the ... Conferred annually, the Innovation Award recognizes a ... cutting edge programs that improves cost and/or quality ... for its clinical and IT solutions that have ...

(Date:5/21/2013)... Two-thirds of patients who have been diagnosed ... that they engage in at least one type of ... findings from the National Health and Wellness Survey ... research will be presented today at the 18th Annual ... Outcomes Research) in New Orleans. , “Cancer ...

Breaking Medicine News(10 mins):Health News:Benefit Express to Host Workplace Wellness Webinar 2 Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2 Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3 Health News:EMBO announces 52 new members for 2013 2 Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2 Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2 Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3

[0] Benefit Express to Host Workplace Wellness Webinar [0] New multi-million dollar research center aims to solve the mystery of premature birth [0] EMBO announces 52 new members for 2013 [0] Healthcare Solutions Receives Innovation Award From Catamaran [0] Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research

... (ASX: PGL; Nasdaq: PGLA) announced today that its ... status by the U.S. Food,and Drug Administration (FDA). ... 88 for the prevention of tumor recurrence following ... primary liver,cancer). Under the FDA Modernization Act ...

... Urgent Health Problems Report Highest Satisfaction When Seen by ... , Patient satisfaction with after-hours care for an urgent ... physician or their physicians after-hours clinic, compared with a ... services. According to a survey of 1,227 patients from ...

... seldom questioned, study found , , MONDAY, Sept. 24 (HealthDay ... some of their neediest patients, a new study suggests ... that raise suicide risk. , U.S. researchers recruited ... showing signs of depression or a similar disorder. , ...

... for her contributions to kidney ... ... a nationwide patient advocacy group comprised of more than 20,000,dialysis and pre-dialysis ... Entitled, Celebrating the Empowerment of,Kidney Patients, the event brought together dialysis patients ...

... N.C., Sept. 24 SalesForce4Hire(R), a provider of,custom ... Science industries,today announced the opening of its new ... allows SalesForce4Hire to expand its custom sales focus ... size of its sales,support call center. This new ...

... Robust Clinical Data Package Provided in NDA Demonstrates ... Safety of Once-Daily Tramadol Formulation, LAVAL, QC, Sept. ... announced that is has requested a meeting with the ... Drug,Application (NDA) for its once-daily formulation of tramadol. Based ...

Cached Medicine News:Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 2 Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 3 Health News:September/October 2007 Annals of Family Medicine tip sheet 2 Health News:September/October 2007 Annals of Family Medicine tip sheet 3 Health News:September/October 2007 Annals of Family Medicine tip sheet 4 Health News:September/October 2007 Annals of Family Medicine tip sheet 5 Health News:September/October 2007 Annals of Family Medicine tip sheet 6 Health News:September/October 2007 Annals of Family Medicine tip sheet 7 Health News:Doctors Often Fail to Spot Suicidal Patients 2 Health News:Doctors Often Fail to Spot Suicidal Patients 3 Health News:Nation's Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care 2 Health News:Nation's Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care 3 Health News:SalesForce4Hire Opens New Office 2 Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 2 Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 3

US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer September/October 2007 Annals of Family Medicine tip sheet Doctors Often Fail to Spot Suicidal Patients Nation's Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care SalesForce4Hire Opens New Office Labopharm provides update on U.S. regulatory process for once-daily Tramadol

... Tango exercise BP monitor is designed to ... and diastolic BP along with heart rate. ... for use in treadmill, ergometer and pharmacological ... for use in research environments., ,Tango ...

...

... Tamp is an orthopedic balloon designed to ... Like an angioplasty balloon, it can be ... is inflated with radiopaque contrast medium. The ... volume. The force of balloon growth compacts ...

Medicine Products:

Tango Exercise Stress BP Monitor BD Visispear Eye Sponge BD Visisorb Absorbent Sticks KyphX Xpander Inflatable Bone Tamp